Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.02 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced outside the brain (extravillous trophoblasts) | 0.10 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 2 Parkinson's papers of 317 | 0.85 |
| pathways Reactome | 1 pathway; mostly other | 0.30 |
No case: the score is under the bar. Receipt 7980
Sealed predictions
- DLX6 in dopamine neurons, braak-0.11 (p 0.784) → -0.22 (p 0.569)receipt 7987
Swarm cases
receipt 7987: DLX6 in dopamine neurons, braak
- power
- full sample -0.41 (p 0.087, n 18), 95% CI -0.74 to +0.07. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.44 (p 0.064, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.41 (p 0.093, n 18). could be the mix.
- skeptic
- leave-one-out range -0.56 to -0.34, sign flips 0; without severely affected donors -0.41 (p 0.087, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for DLX6 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts